Advisors Asset Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Advisors Asset Management’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,148,396	Closed	-$8.91M	–	1848
2015 Q1	$8.91M	Buy	1,148,396 +324,214	+39%	+$153K	0.12%	223
2014 Q4	$6.35M	Buy	824,182 +240,928	+41%	+$514K	0.09%	287
2014 Q3	$4.22M	Buy	583,254 +243,366	+72%	+$1.19M	0.06%	387
2014 Q2	$2.65M	Buy	339,888 +262,823	+341%	+$1.35M	0.04%	511
2014 Q1	$600K	Buy	+77,065	New	+$447K	0.01%	924

Other funds holding NYMX

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return

DIA

Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return

BAS

Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return

Advisors Asset Management's NYMX Position: Q2 2015 in Review

Advisors Asset Management sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2015, closing a stake of 1,148,396 shares — an estimated $8.91M sold.

Advisors Asset Management first reported a position in NYMX in Q1 2014 and held it in 5 quarters. The position peaked at $8.91M in Q1 2015. 23 funds tracked by Wall St. Rank hold NYMX as of Q2 2015.

Advisors Asset Management reported no remaining Nymox Pharmaceutical Corp position as of Q2 2015 after selling out during the quarter.
Advisors Asset Management sold 1,148,396 Nymox Pharmaceutical Corp shares in Q2 2015, an estimated $8.91M.
Advisors Asset Management first reported a position in Nymox Pharmaceutical Corp in Q1 2014 and held it in 5 quarters.
Advisors Asset Management's Nymox Pharmaceutical Corp position peaked at $8.91M in Q1 2015.
23 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2015.

Based on Advisors Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.